Blog

Rosetrees funded scientists have developed a novel cancer therapy that uses MRI to remotely-control magnetic agents that target and destroy hard -to-reach tumours.

This new therapy developed by Professor Mark Lythgoe‘s group at UCL is called “minimally invasive image-guided ablation” or MINIMA. The therapy uses magnetic balls, guided by MRI, generating heat that destroys the tumour without damaging nearby tissue. This proof-of-concept study, published in Advanced Science,  is an exciting potential breakthrough for treating a range of hard-to-treat cancers without the need for invasive surgery.

This work, funded by both Rosetrees Trust and the John Black Charitable Trust, has been picked up today by various news outlets, including The Times, and Sky News.

For full details of the paper published please click the link.